Skip to content

Clinical trials

Scleroderma, Systemic trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Country / region: Argentina Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20162
20224
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Amgen1
EMD Serono Research & Development Institute, Inc.1
EPIMAR registry1
Genentech, Inc.1
GlaxoSmithKline1
Hoffmann-La Roche1
Sanofi1
The Foundation for Orthopaedics and Regenerative Medicine1
Zura Bio Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic13
Lung Diseases, Interstitial4
Scleroderma, Diffuse4
Arthritis, Rheumatoid1
Autoimmune Diseases1
Connective Tissue Diseases1
Immune System Diseases1
Skin Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.